These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 18211588)

  • 1. Medication Quantification Scale Version III: internal validation of detriment weights using a chronic pain population.
    Gallizzi M; Gagnon C; Harden RN; Stanos S; Khan A
    Pain Pract; 2008; 8(1):1-4. PubMed ID: 18211588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medication Quantification Scale Version III: update in medication classes and revised detriment weights by survey of American Pain Society Physicians.
    Harden RN; Weinland SR; Remble TA; Houle TT; Colio S; Steedman S; Kee WG;
    J Pain; 2005 Jun; 6(6):364-71. PubMed ID: 15943958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic-pain medications: equivalence levels and method of quantifying usage.
    Masters Steedman S; Middaugh SJ; Kee WG; Carson DS; Harden RN; Miller MC
    Clin J Pain; 1992 Sep; 8(3):204-14. PubMed ID: 1421733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic pain treatment in a multidisciplinary pain center: do patients adhere to the prescription of the physician?
    Broekmans S; Dobbels F; Milisen K; Morlion B; Vanderschueren S
    Clin J Pain; 2010 Feb; 26(2):81-6. PubMed ID: 20090432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of analgesic use in children with sickle cell disease.
    Jacob E; Miaskowski C; Savedra M; Beyer JE; Treadwell M; Styles L
    Clin J Pain; 2007 Jan; 23(1):8-14. PubMed ID: 17277639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Additional validation of the pain medication questionnaire in a heterogeneous sample of chronic pain patients.
    Buelow AK; Haggard R; Gatchel RJ
    Pain Pract; 2009; 9(6):428-34. PubMed ID: 19735363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of a screener and opioid assessment measure for patients with chronic pain.
    Butler SF; Budman SH; Fernandez K; Jamison RN
    Pain; 2004 Nov; 112(1-2):65-75. PubMed ID: 15494186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polypharmacy and chronic pain: harm exposure is not all about the opioids.
    Giummarra MJ; Gibson SJ; Allen AR; Pichler AS; Arnold CA
    Pain Med; 2015 Mar; 16(3):472-9. PubMed ID: 25280054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Medication Quantification Scale 4.0: An Updated Index Based on Prescribers' Perceptions of the Risk Associated With Chronic Pain Medications.
    De Clifford-Faugère G; Nguena Nguefack HL; Godbout-Parent M; Diallo MA; Guénette L; Gabrielle Pagé M; Choinière M; Harden RN; Beaudoin S; Boulanger A; Pinard AM; Lussier D; De Grandpré P; Deslauriers S; Lacasse A
    J Pain; 2024 Feb; 25(2):508-521. PubMed ID: 37838346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective assessment of cancer pain management in an outpatient palliative radiotherapy clinic using the Pain Management Index.
    Mitera G; Zeiadin N; Kirou-Mauro A; DeAngelis C; Wong J; Sanjeevan T; Sinclair E; Danjoux C; Barnes E; Tsao M; Sahgal A; Chow E
    J Pain Symptom Manage; 2010 Feb; 39(2):259-67. PubMed ID: 20152589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transdermal buprenorphine patches applied in a 4-day regimen versus a 3-day regimen: a single-site, Phase III, randomized, open-label, crossover comparison.
    Likar R; Lorenz V; Korak-Leiter M; Kager I; Sittl R
    Clin Ther; 2007 Aug; 29(8):1591-606. PubMed ID: 17919542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in physicians' practice of prescribing cyclooxygenase-2 inhibitor after market withdrawal of rofecoxib: a retrospective study of physician-patient pairs in Taiwan.
    Hsiao FY; Tsai YW; Huang WF
    Clin Ther; 2009 Nov; 31(11):2618-27. PubMed ID: 20110006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cognitive risk profile for pain: development of a self-report inventory for identifying beliefs and attitudes that interfere with pain management.
    Cook AJ; Degood DE
    Clin J Pain; 2006 May; 22(4):332-45. PubMed ID: 16691085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioids in the management of chronic non-cancer pain: an update of American Society of the Interventional Pain Physicians' (ASIPP) Guidelines.
    Trescot AM; Helm S; Hansen H; Benyamin R; Glaser SE; Adlaka R; Patel S; Manchikanti L
    Pain Physician; 2008 Mar; 11(2 Suppl):S5-S62. PubMed ID: 18443640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving the quality of pain treatment by a tailored pain education programme for cancer patients in chronic pain.
    de Wit R; van Dam F; Loonstra S; Zandbelt L; van Buuren A; van der Heijden K; Leenhouts G; Duivenvoorden H; Huijer Abu-Saad H
    Eur J Pain; 2001; 5(3):241-56. PubMed ID: 11558980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient and physician perceptions of treatment of moderate-to-severe chronic pain with oral opioids.
    Duensing L; Eksterowicz N; Macario A; Brown M; Stern L; Ogbonnaya A
    Curr Med Res Opin; 2010 Jul; 26(7):1579-85. PubMed ID: 20429822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of medication for chronic pain in primary care, and the potential for intervention by a practice-based pharmacist.
    McDermott ME; Smith BH; Elliott AM; Bond CM; Hannaford PC; Chambers WA
    Fam Pract; 2006 Feb; 23(1):46-52. PubMed ID: 16107494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioids for the management of severe chronic nonmalignant pain in children: a retrospective 1-year practice survey in a children's hospital.
    Slater ME; De Lima J; Campbell K; Lane L; Collins J
    Pain Med; 2010 Feb; 11(2):207-14. PubMed ID: 20002597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.